A simplified severity scale for age-related macular degeneration: AREDS Report No. 18 - Wikidata - awgldk - TriplyDB

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

http://www.wikidata.org/entity/Q34655498

about

Blue-light filtering intraocular lenses (IOLs) for protecting macular health Complement in age-related macular degeneration: a focus on function Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study AMD and the alternative complement pathway: genetics and functional implications Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects Microglia in the outer retina and their relevance to pathogenesis of age-related macular degeneration Clinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part II Association between Vascular Endothelial Growth Factor Polymorphisms and Age-Related Macular Degeneration: An Updated Meta-Analysis Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis Copy number variation of age-related macular degeneration relevant genes in the Korean population Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD.A novel source of methylglyoxal and glyoxal in retina: implications for age-related macular degeneration Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.A review of drug options in age-related macular degeneration therapy and potential new agents.Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration Current and emerging therapies for the treatment of age-related macular degeneration Development of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial.The complexities underlying age-related macular degeneration: could amyloid beta play an important role?Reticular pseudodrusen: a risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization.Automated intraretinal segmentation of SD-OCT images in normal and age-related macular degeneration eyes Vitamin E and age-related macular degeneration in a randomized trial of women.Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.Progression of geographic atrophy and genotype in age-related macular degeneration.A circulating microrna profile is associated with late-stage neovascular age-related macular degeneration Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28.Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study Nutritional supplementation and age-related macular degeneration.Complement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue.Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis.Early signs of exudative age-related macular degeneration in Asians Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis.Age-related macular degeneration: genetics and biology coming together.Low-level night-time light therapy for age-related macular degeneration (ALight): study protocol for a randomized controlled trial Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25.Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.Summary results and recommendations from the age-related eye disease study.Genetics of age-related macular degeneration: current concepts, future directions.Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging

P2860

Q24188090-205C8200-AA1A-479A-838B-C4034DBD3EA4 Q24635874-EEEFE2CB-D345-45B5-98BA-B7FA196F50FA Q24647967-2D0BB86D-384B-4D53-9551-4151B561E39D Q26744106-410EC2A6-3E09-4354-8A86-FA44323798A6 Q26774188-83244DC0-3011-4072-AEA6-3184C2E0483B Q26823440-B91BB25B-35D8-4125-8545-95246E323B0D Q26864721-BF01DBD7-FC28-41F3-94B3-BD3F0EF91B80 Q28071947-015BE7F3-F967-4DB8-B69F-AF7A0C696F89 Q28551885-A46C01D2-EF7A-4DA1-8C6F-29D736F50F9E Q28732075-5AB70263-D9DC-456D-B3B1-759C78327623 Q30239897-AD75BA30-6ADD-4654-8708-E3212A9DA561 Q30912692-33F755C5-CEF9-45D5-B6C5-5DBD9F1A2B59 Q31076669-0C63D716-4A2F-4785-A9A4-E8D53F1406C4 Q33263472-0B77B9FF-6D95-4081-8800-C6609F749325 Q33263803-D66ED392-EF7E-495D-82B3-07B0CA2542D0 Q33359481-9A60B9BC-A6FF-4E45-8293-D8DEB92004F5 Q33492370-CB0364F9-BF9E-496F-ADAC-C53E9D9F41A5 Q33676775-D7E68213-1ACD-4888-A2B1-F560BBF69275 Q33702571-93979D96-77F0-4F3C-A355-B9B472DCD807 Q33717512-B10877B5-71DD-49D6-98E7-963E862DDBE0 Q33824861-6F6CCF2D-1A27-480F-9AC6-50403D9A8828 Q33895488-758139EC-6AFC-4EE9-BFB3-841C840B33DD Q33984698-5F18BCC8-167C-470D-AF5F-A387A2F03718 Q33996503-E1D0154C-D530-476B-AEBD-BDADF3230469 Q34156202-B6375CED-0664-4994-B75B-0C974A464D4F Q34164826-504AF866-8169-4B3F-AE64-610805084321 Q34185581-5E901E12-C2E4-43FB-A149-E27B7F8AA7FF Q34187039-A2EBF46B-BF8C-42A2-84A0-BD64549357E2 Q34208123-095F5DCB-B6E7-4E78-A931-ADED080E4D40 Q34216036-A744CF59-993D-4866-8589-A4A4F63C13AA Q34293886-55CE35E2-4768-4482-BDDC-FDF5BDD939CA Q34395891-2B6D3947-E853-4AC0-95CF-F8817F042D40 Q34437319-78F5C6F0-B902-4768-AC70-0B3F1C1B0DE9 Q34440797-EC6EE5C4-6277-4724-9297-B4592ACF4C54 Q34486375-37A097EF-F399-4F1F-BA6D-C10270C11863 Q34491990-CFF2D3ED-8E73-4122-B31D-665302224585 Q34518507-0C4CB55A-9752-434C-8951-48AFB230D5F8 Q34522738-6CA4565D-2BA9-409D-BA47-63D68078E3BC Q34565573-456AE96B-0060-4341-90E7-F3C8C6B265DB Q34575838-67FEEEC9-186B-4E42-946B-603DA9A3E776

P2860

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

http://www.wikidata.org/entity/Q34655498

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

@ast

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

@en

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

@nl

type

label

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

@ast

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

@en

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

@nl

prefLabel

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

@ast

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

@en

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

@nl

P1433

Q34655498-EBC62A52-B78C-4B98-A287-C59C4F17401E

P1476

Q34655498-BA2E12E5-7D5E-4A55-88C9-E1C22827413B

P2093

Q34655498-165E589D-976E-4F6E-AD15-277CA94FF7F5

Q34655498-2D91C44B-5746-4535-B0B1-7402454F0E27

Q34655498-59FAFB8F-648F-463A-BF16-2517EEBA4721

Q34655498-7B6DD93A-49B7-4606-852D-0763EA4F986E

Q34655498-89B6BA86-B03A-4963-9D4A-917757095281

Q34655498-AC21B2AD-B47E-4B27-B1BE-DBDD95B2E34F

Q34655498-C42315BA-61A5-4AD1-88B5-2E93537CFB34

Q34655498-DB5CFA08-0341-4B9E-B5CA-9965CC10D0D7

Q34655498-E109CC27-CBFD-4BFD-AF6B-0EB8926F0B49

P2860

Q34655498-030F3735-187D-411B-A56C-376D8960BE46

Q34655498-0FA9A105-2BD2-49F4-8BA0-661FCA601972

Q34655498-334BC57E-6980-40DA-B60D-C8C79D4DA521

Q34655498-3722822F-5940-49EE-9655-C966B1B95785

Q34655498-50DEE8BD-0852-4227-AE1C-2CE874509937

Q34655498-6433B522-98AF-4227-92EC-3A8BFEDDB42F

Q34655498-730E221A-A133-4522-A891-CB3517A3C337

Q34655498-9C73A959-BFEC-4214-8B70-71B92D2B07FC

P304

Q34655498-72265AF9-D2AD-4F4B-9372-7F87A53C5B83

P31

Q34655498-62E84C97-D697-483B-A110-C50F10EA4C9F

P356

Q34655498-83D495EA-2AEC-468F-8A76-E031CCFC96BF

P407

Q34655498-845A9F30-66AB-40C4-81D0-E6101A6FB196

P433

Q34655498-B9DE4282-B814-4F31-BF4F-480F3D5CF833

P478

Q34655498-5B304BA9-03EC-4F39-8B9E-67FEA81F068B

P50

Q34655498-ACC49C12-18AA-4A71-9FFE-9216A12D4E78

P577

Q34655498-9E5760A0-BE89-4874-B5A3-A38AC0FE8B5D

P5875

Q34655498-80ABD725-1D8B-4E43-863C-2CFEF768D6D7

P698

Q34655498-0D1EB9EE-B593-4B89-881C-CF841FE1B88B

P932

Q34655498-FA56AAD0-3BCD-4D88-956C-07304BB9A8CF

P356

ARCHOPHT.123.11.1570

P1433

JAMA Ophthalmology

P1476

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

@en

P2093

Age-Related Eye Disease Study (AREDS) Research Group

http://www.w3.org/2001/XMLSchema#string

Anne S Lindblad

http://www.w3.org/2001/XMLSchema#string

Frederick L Ferris

http://www.w3.org/2001/XMLSchema#string

Li-Yin Lee

http://www.w3.org/2001/XMLSchema#string

Matthew D Davis

http://www.w3.org/2001/XMLSchema#string

Ronald Klein

http://www.w3.org/2001/XMLSchema#string

Roy C Milton

http://www.w3.org/2001/XMLSchema#string

Susan B Bressler

http://www.w3.org/2001/XMLSchema#string

Traci E Clemons

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.

The Wisconsin age-related maculopathy grading system.

The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6.

Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.

Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort.

The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.

P304

1570-1574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHOPHT.123.11.1570

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7481080

http://www.w3.org/2001/XMLSchema#string

P698

16286620

http://www.w3.org/2001/XMLSchema#string

P932

1473206

http://www.w3.org/2001/XMLSchema#string